B. K. Sharma, P. Pilania, and P. Singh, “QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: Potentially useful in the treatment of inflammatory pain”, Eur. J. Chem., vol. 1, no. 4, pp. 325–334, Dec. 2010.